Doxycycline postexposure prophylaxis has the potential to substantially reduce real-world population-level incidence of ...
Pfizer has further reduced its holding in Haleon, it was confirmed on Wednesday, after the drugs giant offloaded 700m shares ...
GlaxoSmithKline is investing in artificial intelligence (AI) with the hope of radically cutting the time and money needed to develop a drug. It has entered into an alliance with Exscientia ...
Save the Children and GSK have partnered together in the U.S since 2015, providing immediate emergency relief to children and families when disaster strikes and working to build safer and more ...
Despite promising Phase II data, there was no difference in overall survival between the patients who received Canvaxin and the patients who received placebo in the randomized Phase III trial of ...
Below are some of the partners that we have worked with so far with the Pan Africa Chemistry Network. We are always keen to speak to new individuals and organisations who support our ambitions for ...
Gardner, Heidi K., and Silvia Hodges Silverstein. "GlaxoSmithKline: Sourcing Complex Professional Services." Harvard Business School Teaching Note 414-050, May 2014.
We are the state’s flagship institution, home to innovative research and the constant pursuit of knowledge. Together, Jayhawks power Kansas and transform the world. KU innovation powers our state and ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Painkiller brands Panadol and Anadin will be bought under one roof under a giant deal between drug firms GlaxoSmithKline and Pfizer. The firms are combining their consumer healthcare businesses ...
Create a list of the investments you want to track.
Pharmaceutical company GlaxoSmithKline (GSK) has announced it is to shut its antibiotics business at two UK sites. The firm is selling its Zinnat operation to Swiss-owned Sandoz, which will ...